·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
µ¶ÀÚÁ¦º¸
Event
´º½º
Àüü±â»ç
Á¤Ã¥ · ¹ý·ü
Á¦¾à · ¹ÙÀÌ¿À
¾à±¹ · º´¿ø
Ä«µå´º½º
ÆÊTV
À̽´¿µ»ó
DPÃÊ´ë¼®
À̽´Áø´Ü
¾Ë¾Æº¸Àâ
¿ÀÇǴϾð
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
±âÀÚ¼öø
Ưº°±â°í
English
Policy
Opinion
Company
Product
Interview
TVÆÊµµ¶ó
ÆÊTube
ÆÊ¼îÇÎ
³ª´Â¾à»ç´Ù
ÆÊµå¶ó¸¶
ÆÊ¾ÆÄ«µ¥¹Ì
ÃʽÉŬ·¡½º
OTC»ó´ã
Á¦Ç°°ÁÂ
Çмú°ÁÂ
°æ¿µ°ÁÂ
Ä¿¹Â´ÏƼ
ÆÊ¸®Äí¸£Æ®
ä¿ëÁ¤º¸
PHARMARCY
ÀÎÀçÁ¤º¸
DPºÎµ¿»ê
¾à±¹ Q&A
¾à»ç´ëÃâ
¾à»ç½Å¿ë´ëÃâ
¼¼¹«»ó´ã
¼¼¹«·³ë¹«
¹ý·ü»ó´ã
¾à±¹°æ¿µ°úâ¾÷
ÀǾàÀÚ·á½Ç
ÀǾàÇàÁ¤
¾à»ç¾à±¹
ÀǷẴ¿ø
Á¦¾àÀ¯Åë
º¸µµÀÚ·á
ÆÊ½ºÅ¸Å¬·´
ÀÎ»ç · ºÎÀ½
¾à±¹ÀåÅÍ
ȸ»ç¼Ò°³
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
»ç¾÷Á¦ÈÞ
ÀÎÅͳݽŹ®À±¸®°·É
µ¶ÀÚÁ¦º¸
±âÀÚÀ±¸®°·É
ÀÚÀ²¼¾à¼
¿ø°ÝÁö¿ø¿äû
Event & ¼¼¹Ì³ª
Àüü±â»ç
±×·¡ÇÈ
Á¤Ã¥¡¤¹ý·ü
Á¦¾à¡¤¹ÙÀÌ¿À
¾à±¹¡¤º´¿ø
±âȹ¡¤Å½»ç
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
񃯇
񃯇
ÀǾàǰ
³¹¾Ë½Äº°
µ¥Àϸ®ÆÊ Live Search
´Ý±â
´º½º
>
Àüü ±â»ç
Àüü Çìµå¶óÀÎ ±â»ç
Àüü
|
07-18 (±Ý)
|
07-17 (¸ñ)
|
07-16 (¼ö)
|
07-15 (È)
|
07-14 (¿ù)
|
07-13 (ÀÏ)
|
07-12 (Åä)
ÀÇÇù "ÀÇ·áÁ¤»óÈ Àû±Ø Çù·Â"...ÀÌ ´ëÅë·É ¹ß¾ð¿¡ È´ä
2025-07-15 13:17:39
[µ¥Àϸ®ÆÊ=°½Å±¹ ±âÀÚ] ÀÌÀç¸í ´ëÅë·ÉÀÇ ÀÇ·á Á¤»óÈ ¹ß¾ð¿¡ ÀÇ»ç´Üü°¡ Àû±Ø Çù·ÂÇÏ°Ú´Ù°í ¹àÇô »õ Á¤ºÎ¿Í ÀÇ·á°è°£ ÈÇØ¸ðµå°¡ Áö¼ÓµÇ°í ÀÖ´Ù. ´ëÇÑÀÇ»çÇùȸ(ȸ...
°½Å±¹ ±âÀÚ
"COPD Á¤º¹Çغ¼±î"...±Û·Î¹úÁ¦¾à ¹ÙÀÌ¿À½Å¾à ´ë°Å ÂüÀü
2025-07-15 12:10:27
[µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] ÁÖ¿ä ±Û·Î¹úÁ¦¾à»çµéÀÌ »ý¹°ÇÐÀûÁ¦Á¦¸¦ ¾Õ¼¼¿ö ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD) ÀûÀÀÁõ È®º¸¿¡ ¼Óµµ¸¦ ³»°í ÀÖ´Ù. Áö³ÇØ »ç³ëÇÇ¡¤¸®Á¦³×·ÐÀÇ µàÇÇÁ¨Æ®...
¼ÕÇü¹Î ±âÀÚ
"±âÇüÀû ¾à±¹ ³¸³ ¸·¾Æ´Þ¶ó"¡¦¾à»çȸ, º¸°Ç¼Ò¿¡ SOS
2025-07-15 12:09:26
[µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] â°íÇü¡¤¸¶Æ®Çü ¾à±¹ °°Àº ±âÇüÀû ¾à±¹ ³¸³À» ¸·±â À§ÇØ ¾à»ç´Üü°¡ Àü±¹ º¸°Ç¼Ò¿¡ ÇùÁ¶¸¦ ¿äûÇß´Ù. ´ëÇѾà»çȸ(ȸÀå ±Ç¿µÈñ)´Â ÃÖ±Ù Àü...
°Çý°æ ±âÀÚ
"ÅÎ¹Ø Áö¹æ ºÐÇØ 'ºêÀ̿÷¿' ÆÈ¶Ò»ì Á¦°Å ½Ã¼ú¿¡µµ È¿°ú"
2025-07-15 12:09:18
[µ¥Àϸ®ÆÊ=±èÁø±¸ ±âÀÚ] ´ë¿õÁ¦¾àÀÌ ÅÎ¹Ø Áö¹æ ºÐÇØ ÁÖ»çÁ¦ÀÎ ¡®ºêÀ̿÷¿(µ¥¿Á½ÃÄÝ»ê)¡¯ÀÇ ½Ã¼ú ¹üÀ§ È®´ë¸¦ ¿¹°íÇß´Ù. ºêÀ̿÷¿Àº ÇöÀç ¡®¼ºÀÎÀÇ ÁßµîÁõ¡¤ÁßÁõÀÇ ...
±èÁø±¸ ±âÀÚ
Äڷγª ÀçÀ¯Çà¿¡ 'ÆÅ½º·Îºñµå' ºÐ±â ó¹æ 100¾ï µ¹ÆÄ
2025-07-15 12:05:32
[µ¥Àϸ®ÆÊ=±èÁø±¸ ±âÀÚ] Äڷγª19 Ä¡·áÁ¦ ÆÅ½º·ÎºñµåÀÇ ºÐ±â 󹿾×ÀÌ 100¾ï¿øÀ» ³Ñ¾î¼¹´Ù. ÀÛ³â 10¿ù 󹿽ÃÀå¿¡ ÁøÀÔÇÑ ÀÌÈÄ ºü¸£°Ô »ç¿ë·®ÀÌ ´Ã¸é¼ ´©Àû 󹿾×Àº ...
±èÁø±¸ ±âÀÚ
â°íÇü¾à±¹ ´ëÃ¥ ³»³ù´ø ¼¿ï ºÐȸÀåµé, ¿À´Ã ¶Ç ¸ðÀδÙ
2025-07-15 12:01:20
[µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] â°íÇü¾à±¹ ¹®Á¦¿¡ ´ëÇÑ Á¤Ã¥Àû º¸¿Ï Çʿ伺À» Ã˱¸Çß´ø ¼¿ï 24°³ ºÐȸÀåµéÀÌ ¿À´Ã(15ÀÏ) ¸ð¿© ÈÄ¼Ó ³íÀǸ¦ À̾´Ù. ºÐȸÀåÇùÀÇȸ´Â ¾Õ...
Á¤ÈïÁØ ±âÀÚ
PDRN¡¤Äݶó°Õ¡¤¿¢¼ÒÁ» 'Çѹø¿¡'¡¦¸®Áêµåºñ¿¡ Å©¸² Ãâ½Ã
2025-07-15 12:00:49
[µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] PDRN°ú Äݶó°Õ, ¿¢¼ÒÁ» 3°¡Áö ¼ººÐÀ» ÇÔÀ¯ÇÑ ÇǺÎÀç»ýÅ©¸² ¸®Áêµåºñ¿¡°¡ Ãâ½ÃµÅ ¾à±¹ À¯ÅëÀ» ¾ÕµÎ°í ÀÖ´Ù. ±¤µ¿»ýȰ°Ç°(´ëÇ¥ ¾ö½Â¼·)Àº Àç...
°Çý°æ ±âÀÚ
¾à±¹ ¾Õ ÀǾàǰ ¹è¼Û °³¼±µÉ±î¡¦¾à»çȸ, ½ÇÅ Á¶»ç
2025-07-15 12:00:41
[µ¥Àϸ®ÆÊ=±èÁöÀº ±âÀÚ] ¾à±¹ ¹®¾Õ ÀǾàǰ ÅÃ¹è ¹è¼Û ¹®Á¦°¡ È®»êµÇ¸é¼ ¾à»çȸ°¡ »çÅ ÆÄ¾Ç°ú ´ëÀÀ ¹æ¾È ¸¶·Ã¿¡ µé¾î°£ °ÍÀ¸·Î È®ÀεƴÙ. 14ÀÏ ´ëÇѾà»çȸ¿¡ µû...
±èÁöÀº ±âÀÚ
ÀÌ ´ëÅë·É "ÀÇ´ë»ý º¹±Í ´ÙÇࡦÈÄ¼Ó Á¶Ä¡¿¡ ¸¸ÀüÀ»"
2025-07-15 11:42:16
[µ¥Àϸ®ÆÊ=ÀÌÁ¤È¯ ±âÀÚ] ÀÇ´ë»ý Àü¿øÀÌ Çо÷¿¡ º¹±ÍÇϱâ·Î °áÁ¤ÇÑ °¡¿îµ¥ ÀÌÀç¸í ´ëÅë·ÉÀÌ ±³À°ºÎ¸¦ ÇâÇØ ÇÊ¿äÇÑ ÈÄ¼Ó Á¶Ä¡¸¦ ½Å¼ÓÇÏ°Ô ÃßÁøÇ϶ó°í ´çºÎÇß´Ù. ÀÌÀç...
ÀÌÁ¤È¯ ±âÀÚ
´ëÇѹα¹¾àÀü, ±¹Á¦¾àÀüÀÎÁõÇùÀÇü Á¤È¸¿ø Èĺ¸ ¼±Á¤
2025-07-15 11:12:57
[µ¥Àϸ®ÆÊ=ÀÌÇý°æ ±âÀÚ] ½ÄǰÀǾàǰ¾ÈÀüó(óÀå ¿ÀÀ¯°æ)´Â 11ÀÏ ´ëÇѹα¹¾àÀü(KP) ÀÌ ±¹Á¦¾àÀüÀÎÁõÇùÀÇü(Pharmacopoeia Discussion Group) Á¤È¸¿ø È帷Π¼±Á¤µÆ´Ù°í ...
ÀÌÇý°æ ±âÀÚ
1
2
3
4
5
ä¿ë
¼Óº¸
ÁÖ¹®½Ã °áÁ¦±Ý¾×ÀÇ 5% Áï½Ã ÇÒÀÎ!
[¾¾¸®¾ó¸¶ÄÏ] ¹Ù»èÇÑ ¼ÓÃÊ ¸ÔÅÂ
46%
18,900
È«»ïÁ¤ ¿¡ºê¸®Å¸ÀÓ ·Õ±â½ºÆ®
65%
31,900
¹Ì¶óŬÅ彺 ¾îµå¹ê½ºµå ¸®ÇÁÆÃ ¾ÚÇÃ
50%
44,000
¾ß»ý ºôº£¸®&¶óÁ¸® 6ÆÑ
25%
32,300¿ø
[Á¤°üÀå] Àå»ý±âº¸ 30Æ÷
50%
149,000
ºí·¢¾Þ°Å½º LA²É°¥ºñ ¼±¹°¼¼Æ®
79%
53,500
¿Ãµ¥ÀÌ KF94 ¸¶½ºÅ©
8%
250¿ø
[¿À¶óƽ½º] ±¸°À¯»ê±Õ 5°³¿ùºÐ
62%
85,500¿ø
[Çϸ²] ¿ë°¡¸® ġŲ³Ê°Ù 1+1
38%
17,005¿ø
ÄÚÄÚ½ºÅ丮 360 ¸¶±×³×½· ½ºÇÁ·¹ÀÌ
42%
7,000
[¶ó¿¤] À¯±â³ó ¼ø¸é »ý¸®´ë
34%
5,605¿ø
µ¿¿ø °Ç°ÇÑÂüÄ¡ ¼±¹°¼¼Æ®
30%
35,500
µå¸²ÀÌÀ½ ¾ËÆÄ½ÃŬ·Î µ¦½ºÆ®¸° ´ÙÀÌ·ºÆ® ¾ËÆÄ
35%
11,000
[¿À¶óƽ½º] ÀÓÇöõƽ½º 5°³¿ùºÐ
61%
118,750¿ø
¹Ù¸£´Â ÆÄ½º Ä𸵠½ºÆ÷Ã÷°Ö
5%
9,500¿ø
¹Ì¶óŬÅ彺 ¾îµå¹ê½ºµå ÆäÀÌ¼È Å¬·»Àú
50%
27,500
ÀÓ»êºÎ ¸®Æ÷ÆÛ ¾×»ó öºÐÁ¦
50%
15,000
[¸ÅÁ÷½¦ÇÁ] ¹Ì´Ï Á¦½À±â
37%
35,625
µ¿¿øÂüÄ¡ Á¾ÇÕ A1È£
30%
17,500
Çã´Ï¿¡¼¾½º ¸®À¯ÀúºíÄÅ ²Ü ¼±¹°¼¼Æ®
29%
34,300
¾ÆÀÌ¿ø Ŭ¸®³Ê¼¼Á¤ 20¸ÅÀÔ
12%
88,825¿ø
°üÀý¿£ ö°©»ó¾î&¼Ò¿¬°ñ Äܵå·ÎÀÌÄ£ ¹ÂÄÚ´Ù´ç´Ü¹é
26%
14,700
[»ïÇö] ¼Òµ¶¿ë¿¡Åº¿Ã
5%
760¿ø
NEW ûÁ¤¿ø Á¤¼º12È£
37%
17,900
¾Ë¸² ¡¤ °øÇ¥
±³À° ¡¤ °ÁÂ
¾à±¹ Q&A
Á¢¼ö ¡¤ ¹®ÀÇ
°øÇ¥
(ÁÖ)Çѱ¹ÈÞÅØ½ºÁ¦¾à ÀǾàǰ ȸ¼ö¿¡ °üÇÑ °øÇ¥
°øÇ¥
(ÁÖ)ÆÊÁ¨»çÀ̾𽺠ÀǾàǰ ȸ¼ö¿¡ °üÇÑ °øÇ¥
¾Ë¸²
[µ¿¾ÆÁ¦¾à]Å»¸ð»ó´ãÀÇ ÇØ´ä, Ä«ÇÊ·¯½º À̺¥Æ® GO¢º
¾Ë¸²
ÆÊ½ºÅ¸Å¬·´ ·ê·¿ÄíÆù ¡æ ÆÊÆ÷ÀÎÆ® ±³È¯ À̺¥Æ® GO ¢º
°øÇ¥
JW½Å¾à ÀǾàǰ(³ª¹«Á¹Á¤) ȸ¼ö¿¡ °üÇÑ °øÇ¥
¾Ë¸²
ÁøÅëÁ¦ ½À°ü Àâ´Â ±â¼ú! ʼ¾ »ó´ã °¡ÀÌµå ¹Þ±â ¢º
¾Ë¸²
½Å°³³ä »êÁ¦Çü ¸Ö¹Ì¾à, ½ºÅä¸Ö»ê! POP & ¹æ¹®½Åû ¢º
°øÇ¥
JW½Å¾à ÀǾàǰ(ÆÄ³ª´ýÅ©¸²) ȸ¼ö¿¡ °üÇÑ °øÇ¥
D-111
ij³ª´Ù¾à»ç ½ÃÇè, ÀÌ·¸°Ô ¹Ù²ï´Ù! ( ~12.31 )
D-111
¾à¾÷°è ´ëÇ¥ ±³À°»çÀÌÆ®, ÆÊŬ·¡½º ( ~12.31 )
D-5
SGLT ¾ïÁ¦Á¦ ÇÙ½É º¹¾àÁöµµ ¢º»çÀü½Åû ( ~9.16 )
D-8
PV ¾÷¹«¿ª·® °È±³À° ¼ö°½Åû ¢º ( ~9.19 )
D-15
ÈѽºÅ»·Î Àд ¼ÒÈÁ¦ Æ®·»µå µî·Ï¢º ( ~9.26 )
¼¼¹«»ó´ã
±Ç¸®±ÝÀ» ³ª´²¼ ½Å°í ÇÒ ¼ö µµ ÀÖ³ª¿ä?
ÀÚ»ê°ü¸®
Á¾½Åº¸Çè °è¾àÀÚ¿Ü ¼öÀÍÀÚ º¯°æ °¡´ÉÇѰ¡¿ä?
¼¼¹«¡¤³ë¹«
(±Ù¹«¾à»ç ÁßµµÅð»ç) Ãß°¡ Áú¹®µå¸³´Ï´Ù
¾à±¹°æ¿µ°ú â¾÷
¾à±¹Ã¢¾÷°ü·Ã
¾à±¹´ëÃâ
¾à±¹¿î¿µÀÚ±Ý
¹ý·ü»ó´ã
¸éÇã´ë¿©¾à±¹¿¡´ëÇÑ Áú¹®
±³À° °Á ¹× ¾Ë¸² ±¤°í ¾È³» ÆäÀÌÁö
¿¬¼ö, ±³À°, ¼¼¹Ì³ª, Çмú°Á ¹× ±â¾÷±³À°, ¸ðÁý
°øÇ¥, Åä·Ðȸ, ÀǾàǰ º¯°æ ¾È³» ¹× °¢Á¾ Çà»ç
¾Ë¸² ±¤°í¸¦ ÇØµå¸³´Ï´Ù.
(Á¢¼ö ¹®ÀÇ ¹Ù·Î°¡±â)
¿À´ÃÀÇ
ÇÖ´º½º
1
¹ÙÀÌ¿À CMO»ç¾÷ ½Ç¼Ó Çຸ...¿ª´ë ±â¼ú¼öÃ⺸´Ù ¿ùµî
2
SCI Ä¡·á È¿°ú ù ±Ô¸í¡¦ÇϹݽЏ¶ºñ Ä¡·á±æ ¿¸®³ª
3
"º´¿ø-¾à±¹ ´ãÇÕ ¾Ö¸ÅÇϳ×"¡¦ÁöÀÚüµµ 'ÀüÀü±à±à'
4
º¹ÁöºÎ, Çõ½ÅÇüÁ¦¾à ÀÎÁõ 'Á¡¼öÁ¦ °³Æí¾È' ³ª¿Â´Ù
5
Á¦¾à¡¤À¯Åë¾÷°è "ÇѾà»ç ¾à±¹ ÀÏ¹Ý¾à °ø±Þ Á¤ºÎ Áöħ ´Þ¶ó"
6
½Ç°Å·¡°¡¡¤ÀçÆò°¡ µî ¾àÁ¦ »çÈİü¸® °³¼±¾È ÅëÇÕ ³íÀÇ
7
[±âÀÚÀÇ ´«] '1¾à»ç ´Ù¾à±¹' ¿î¿µÀÌ ¹ÌÄ¥ ÆÄÀå
8
ÆíÀǼº °³¼±¡¤ºÎÀÛ¿ë ¿¹¹æ...·º¶óÀÚ º´¿ë ÀÓ»ó±Ù°Å ÃàÀû
9
SLS¹ÙÀÌ¿À ǰÁú°Ë»ç ÆÄÀå È®»ê...½Ä¾àó, ÇàÁ¤Áö¿ø ³íÀÇ
10
°³² À§ÀåÁ¡Æ÷ ³í¶õ Ãþ¾à±¹, µÎ ´Þ¸¸¿¡ °³¼³ Çã°¡